Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Industrial Select Sector SPDR Fund
XLI
|
+$236M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$137M |
| 4 |
VMW
VMware, Inc
VMW
|
+$109M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$104M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.21B |
| 2 |
Apple
AAPL
|
+$779M |
| 3 |
Microsoft
MSFT
|
+$629M |
| 4 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$601M |
| 5 |
AABA
Altaba Inc. Common Stock
AABA
|
+$384M |
Sector Composition
| 1 | Technology | 15.35% |
| 2 | Healthcare | 12.15% |
| 3 | Financials | 11.41% |
| 4 | Consumer Discretionary | 9.92% |
| 5 | Communication Services | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Eagle Bancorp
EGBN
$618M
| $469K | ﹤0.01% |
7,653
+957
| +14% | +$58.6K |
|
|
RDUS
2252
DELISTED
Radius Recycling
RDUS
| $469K | ﹤0.01% |
13,896
-3,002
| -18% | -$101K |
|
2253
Webster Financial
WBS
$9.89B
| $469K | ﹤0.01% |
7,354
+1,665
| +29% | +$106K |
|
2254
Energy Recovery
ERII
$778M
| $468K | ﹤0.01% |
57,973
-29,278
| -34% | -$236K |
|
2255
Radware
RDWR
$1.09B
| $468K | ﹤0.01% |
18,512
-4,553
| -20% | -$115K |
|
|
ESIO
2256
DELISTED
Electro Scientific Industries
ESIO
| $468K | ﹤0.01% |
29,634
+1,769
| +6% | +$27.9K |
|
2257
Triumph Financial, Inc.
TFIN
$1.38B
| $467K | ﹤0.01% |
11,456
+4,997
| +77% | +$204K |
|
2258
CareTrust REIT
CTRE
$7.6B
| $466K | ﹤0.01% |
27,865
+1,420
| +5% | +$23.7K |
|
2259
iShares 0-5 Year TIPS Bond ETF
STIP
$12.8B
| $466K | ﹤0.01% |
4,675
| – | – |
|
2260
Constellium
CSTM
$2.09B
| $465K | ﹤0.01% |
45,001
-123,122
| -73% | -$1.27M |
|
2261
Atlantic Union Bankshares
AUB
$4.95B
| $464K | ﹤0.01% |
11,933
-7,099
| -37% | -$276K |
|
2262
Weis Markets
WMK
$1.78B
| $463K | ﹤0.01% |
8,691
+6,704
| +337% | +$357K |
|
|
ALEX
2263
Alexander & Baldwin
ALEX
$1.33B
| $462K | ﹤0.01% |
19,638
-519
| -3% | -$12.2K |
|
2264
iShares Russell 2000 Value ETF
IWN
$11.8B
| $460K | ﹤0.01% |
3,482
+2,120
| +156% | +$280K |
|
|
VIVO
2265
DELISTED
Meridian Bioscience Inc
VIVO
| $460K | ﹤0.01% |
28,886
-1,606
| -5% | -$25.6K |
|
2266
Karyopharm Therapeutics
KPTI
$54.3M
| $459K | ﹤0.01% |
1,803
-1,063
| -37% | -$271K |
|
|
NOAH
2267
Noah Holdings
NOAH
$765M
| $459K | ﹤0.01% |
+8,800
| New | +$459K |
|
2268
Team
TISI
$81.3M
| $457K | ﹤0.01% |
1,979
+1,055
| +114% | +$244K |
|
|
ONCE
2269
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $457K | ﹤0.01% |
5,512
-10,559
| -66% | -$875K |
|
2270
Gyre Therapeutics
GYRE
$689M
| $454K | ﹤0.01% |
5,186
+4,795
| +1,226% | +$420K |
|
2271
HealthStream
HSTM
$860M
| $454K | ﹤0.01% |
16,584
+7,140
| +76% | +$195K |
|
|
DBD
2272
DELISTED
Diebold Nixdorf Incorporated
DBD
| $454K | ﹤0.01% |
37,903
-32,636
| -46% | -$391K |
|
2273
Gold Resource Corp
GORO
$121M
| $453K | ﹤0.01% |
68,720
+26,921
| +64% | +$177K |
|
|
NPKI
2274
NPK International Inc.
NPKI
$919M
| $453K | ﹤0.01% |
41,773
+11,438
| +38% | +$124K |
|
2275
Marcus & Millichap
MMI
$1.24B
| $452K | ﹤0.01% |
11,578
-23,687
| -67% | -$925K |
|